Assoc. Prof. Dr. Amir hossein Taromchi | Immunology | Best Researcher Award

Published on by Academic Achievements

Assoc. Prof. Dr. Amir hossein Taromchi | Immunology | Best Researcher Award

Assoc. Prof. Dr. Amir hossein Taromchi | Immunology – Reearcher at Zanjan University of Medical Sciences, Iran

Dr. Amir Hossein Taromchi is an esteemed Associate Professor at Zanjan University of Medical Sciences (ZUMS), specializing in Medical Biotechnology and Nanotechnology within the Faculty of Medicine. With an extensive academic background, Dr. Taromchi has contributed significantly to the fields of molecular diagnostics, recombinant proteins, and gene therapy, particularly focusing on cancer research and the development of diagnostic and therapeutic biotechnologies. His journey in academia and research has allowed him to mentor numerous graduate students and lead various projects with profound clinical implications.

Profile Verified:

Orcid | Scopus | Google Scholar

Education:

Dr. Taromchi earned his Ph.D. in Medical Biotechnology from Shahid Beheshti University of Medical Sciences, Tehran, in 2013, where he was honored for his excellence in comprehensive exams. His research focused on the molecular cloning and expression of human IL-29 (IFN-λ1) in Iranian Lizard Leishmania, a critical contribution to understanding the molecular biology of infectious diseases. Prior to this, he obtained an M.Sc. in Medical Virology from Iran University of Medical Sciences and a B.Sc. in Microbiology Sciences from Islamic Azad University, Zanjan Branch. His academic credentials lay a strong foundation for his future work in molecular diagnostics and recombinant technology.

Experience:

Dr. Taromchi’s career spans over two decades, during which he has gained valuable research and teaching experience. He served as a research assistant at the Avecina Research Center and later worked on a variety of molecular diagnostics projects at the Karimi-Nejad-Najmabadi Genetics and Pathology Center in Tehran. His academic experience includes being a lecturer at Azad University, Zanjan, where he taught courses on virology, molecular biology, and biotechnology. At ZUMS, he continues to serve as both a researcher and educator, supervising a range of graduate theses focused on cutting-edge biotechnological innovations. Additionally, Dr. Taromchi is currently the head of the Cancer Gene Therapy Research Center, further cementing his role in advancing cancer biotechnology.

Research Interests:

Dr. Taromchi’s research interests are diverse, focusing primarily on molecular diagnostics, genetic disorders, and cancer therapeutics. He is particularly invested in the development of rapid molecular diagnostic tools for infectious diseases and human genetic disorders, including cancers. His work also explores recombinant protein expression, the development of vaccines, and the use of nanotechnology in medical applications, particularly in gene therapy and targeted drug delivery systems. These research areas highlight his commitment to improving healthcare through innovative biomedical solutions.

Awards:

Throughout his academic and research career, Dr. Taromchi has earned several accolades, including first rank in the PhD entrance examination for medical biotechnology. His excellence in research has earned him recognition in both national and international platforms. Furthermore, he has received numerous fellowships and distinctions, solidifying his standing as a leader in his field.

Publications:

Dr. Taromchi has authored several peer-reviewed articles and contributions to academic books, shedding light on key advancements in biotechnology and molecular diagnostics. Some notable publications include:

  1. Taromchi A.H., Kazemi B., Mahmazi S., Bandehpour M. “Heterologous expression of human IL-29 (IFN-λ1) in Iranian Lizard Leishmania.” Iranian Journal of Biotechnology (2013). 📝
  2. Taromchi A.H., Kariminejad R., Zanganeh M., Imanian H., Nayeb bagher T., Najmabadi H. “Multiplex reverse transcription polymerase chain reaction for simultaneous screening of 7 translocations.” Tashkhis Azmayeshghahi (2002). 📝
  3. Gholinejad M., Abdanipour A., Taromchi A.H. “Adenosine decreases oxidative stress and protects H2O2-treated neural stem cells against apoptosis through decreasing Mst1 expression.” Biomedical Reports (2018). 📝
  4. Dehghani S., Sabzehei F., Taromchi A.H., Mobaien A.R., Arsang-Jang S. “Hybrid recombinant Omp 22, 25, and 31 immunodominant epitopes can be used for serodiagnosis of brucellosis.” Journal of Immunological Methods (2021). 📝

Conclusion:

Dr. Amir Hossein Taromchi stands as a prominent figure in the realm of medical biotechnology, with an academic and research career spanning over 20 years. His work in molecular diagnostics, recombinant proteins, cancer gene therapy, and nanotechnology has not only earned him significant recognition but also contributed to the advancement of medical biotechnology in Iran and globally. Through his dedication to teaching, research, and innovation, Dr. Taromchi continues to inspire the next generation of biotechnologists, researchers, and medical professionals. His contributions to the field remain invaluable, particularly in the areas of molecular diagnostics and cancer therapeutics.

 

 

 

Minkyoung Cho | Immune disorders | Best Researcher Award

Published on by Academic Achievements

Prof Minkyoung Cho | Immune disorders | Best Researcher Award

Assistant Professor at Gyeongsang National University, South Korea

Dr. Minkyoung Cho is an accomplished researcher and academic in the fields of parasitology, immunology, and tropical medicine. With a strong foundation in biomedical science, microbiology, and immunology, she has dedicated her career to advancing understanding in parasite-host interactions, immune regulation, and therapeutic applications of natural products. Dr. Cho earned her Ph.D. from Pusan National University and has held prestigious postdoctoral and research positions in Korea and the USA. Currently, she serves as an Assistant Professor at Gyeongsang National University, where she continues her groundbreaking research. Her work has led to multiple patents and numerous high-impact publications, focusing on areas such as autoimmune diseases, endometriosis, and anti-aging therapies. Dr. Cho is also a recipient of several awards, including the Parasite Immunology Woods Hole Prize and the Young Scientist Prize, highlighting her contributions to immunology and parasitology.

Profile

Orcid

Scopus

Education 🎓

Dr. Minkyoung Cho’s academic journey began with a Bachelor of Science in Biomedical Science from Inje University (2003-2007). She then pursued her Master’s (2007-2009) and Ph.D. (2009-2012) in Microbiology and Immunology at Pusan National University, where she developed a strong foundation in immunology and parasitology. Her doctoral research focused on parasite-host interactions, laying the groundwork for her future contributions to the field. Dr. Cho’s education equipped her with the skills to explore complex immunological mechanisms and their applications in medicine, particularly in autoimmune diseases and parasitic infections. Her academic excellence and research potential were evident early on, earning her recognition through awards and scholarships. This robust educational background has been instrumental in her successful career as a researcher and professor.

Experience 💼

Dr. Minkyoung Cho has a diverse and impressive professional background. She began as a Teaching Assistant at Pusan National University (2010-2012), followed by postdoctoral roles at Pusan National University Medical Research Institute (2012-2013) and Georgia State University, USA (2013-2014). She then served as a Research Assistant Professor at Seoul National University (2014-2019) and a Research Professor at the Healthy Aging Korean Medical Research Center (2020-2023). Currently, she is an Assistant Professor at Gyeongsang National University (2024-present). Her roles have spanned teaching, research, and mentorship, with a focus on immunology, parasitology, and therapeutic development. Dr. Cho’s international experience and interdisciplinary approach have significantly contributed to her expertise in immune regulation, autoimmune diseases, and natural product-based therapies.

Awards and Honors 🏆

Dr. Minkyoung Cho has been recognized with numerous awards for her contributions to immunology and parasitology. These include the Research Achievement Award (2018) and Best Research Award (2017) from the Korean Association of Immunologists, the Young Scientist Prize (2018) from the Dendritic Cell Symposium, and the Parasite Immunology Woods Hole Prize (2012). She has also received multiple Best Oral Presentation Awards at the Korean Society for Parasitology conferences (2009, 2010). These accolades highlight her excellence in research, innovation, and scientific communication. Her work on parasite-derived proteins and immune regulation has not only advanced scientific understanding but also opened new avenues for therapeutic development, earning her a distinguished reputation in her field.

Research Focus 🔬

Dr. Minkyoung Cho’s research focuses on immune regulation, parasitic infections, and therapeutic applications of natural products. Her work explores the mechanisms of autoimmune diseases, such as allergic asthma and neuroinflammation, and the role of parasitic proteins in modulating immune responses. She has also investigated the anti-aging and wound-healing properties of parasite-derived proteins. Additionally, Dr. Cho studies the therapeutic potential of natural compounds, such as andrographolide and frankincense, in treating endometriosis, cancer, and inflammatory diseases. Her research integrates molecular biology, immunology, and bioinformatics to identify novel biomarkers and therapeutic targets. By bridging parasitology and immunology, Dr. Cho’s work has significant implications for developing innovative treatments for immune-related disorders and improving human health.

Publication Top Notes 📚

  1. Genetic polymorphism of Duffy binding protein in Pakistan Plasmodium vivax isolate. Acta Trop., 2024.
  2. Frankincense ameliorates endometriosis via inducing apoptosis and reducing adhesion. Integr Med Res., 2023.
  3. Andrographolide suppresses aerobic glycolysis and induces apoptotic death by inhibiting pyruvate dehydrogenase kinase 1 expression. Oncol Rep., 2023.
  4. Identification and analysis of novel endometriosis biomarkers via integrative bioinformatics. Front. Endocrinol., 2022.
  5. Water-Extracted Prunella vulgaris alleviates endometriosis by reducing aerobic glycolysis. Front Pharmacol, 2022.
  6. Trichinella spiralis nurse cell formation is regulated via CCR7+ dendritic cells. Parasite Immunol., 2022.
  7. Autophagy as a Therapeutic Target of Natural Products Enhancing Embryo Implantation. Pharmaceuticals (Basel)., 2021.
  8. Drug evaluation based on phosphomimetic PDHA1 reveals the complexity of activity-related cell death in A549 non-small cell lung cancer cells. BMB Rep. 2021.
  9. A critical role for Th17 cell-derived TGF-β1 in regulating the stability and pathogenicity of autoimmune Th17 cells. Exp Mol Med., 2021.
  10. A critical regulation of Th2 cell responses by RORα in allergic asthma. Science China. Life Sciences, 2020.
  11. A critical regulation of Th17 cell responses and autoimmune neuro-inflammation by ginsenoside Rg3. Biomolecules, 2020.

Conclusion 🌟

Dr. Minkyoung Cho is a distinguished researcher and educator whose work in immunology, parasitology, and natural product-based therapies has made significant contributions to science and medicine. Her innovative research, numerous awards, and impactful publications reflect her dedication to advancing knowledge and developing novel treatments for immune-related diseases. As an Assistant Professor at Gyeongsang National University, she continues to inspire and lead in her field, paving the way for future breakthroughs.

 

Sukdeb Nandi | Veterinary Virology | Best Researcher Award

Published on by Academic Achievements

Prof Dr. Sukdeb Nandi | Veterinary Virology | Best Researcher Award

Professor at Indian Veterinary Research Institute, India 

Dr. S. Nandi is a distinguished Principal Scientist at the Indian Veterinary Research Institute (I.V.R.I.), Izatnagar. With an illustrious academic background, he earned his Ph.D. in Veterinary Virology from I.V.R.I., complemented by a diploma in German language. Throughout his 31-year career, Dr. Nandi has specialized in virological, immunological, and molecular biological research, focusing on diseases such as FMD, Rabies, and SARS-CoV-2. His contributions extend beyond research to encompass teaching, training, and international collaborations, exemplified by his FAO-sponsored training in Australia. Dr. Nandi’s work is underscored by numerous publications and a commitment to advancing veterinary science and disease control strategies.

Author Profile

Scopus Profile

Education

Dr. S. Nandi’s educational journey includes matriculation from W.B.B.S.E in 1978 and higher secondary education from W.B.C.H.S.E in 1980, both with first-class distinctions. He obtained his B.V.Sc & A.H. from B.C.K.V. in 1986, ranking third in his class. His pursuit of higher education led to an M.V.Sc in Vety. Virology from I.V.R.I. in 1988 and a Ph.D. in the same discipline from I.V.R.I. in 1992, both earned with first-class honors. Additionally, he completed a diploma in German language from Max Muller Bhavan in 1991.

Research Focus

Dr. S. Nandi has dedicated his research career to virological, immunological, and molecular biological aspects of various diseases including Foot and Mouth Disease (FMD), Rabies, Sheep pox, Goat pox, Bluetongue, BHV-1, PPR, Canine viruses (e.g., Canine parvovirus, Canine Adenovirus, Canine distemper virus), Porcine viruses (e.g., Porcine Circovirus 2, BVDV), and more recently, SARS-CoV-2. His research spans both fundamental virology and practical applications in disease diagnosis and control.

Professional Journey

Dr. S. Nandi embarked on his professional journey as a Principal Scientist at the Indian Veterinary Research Institute (I.V.R.I.), Izatnagar. His role encompasses research, teaching, training, and extension activities in Veterinary Virology. He has over 31 years of experience in teaching Veterinary Virology courses at M.V.Sc and Ph.D. levels, alongside conducting extensive research in viral diseases affecting livestock and pets.

Honors & Awards

Throughout his illustrious career, Dr. S. Nandi has been recognized for his contributions to Veterinary Virology and public health. His achievements include awards for excellence in research and teaching, as well as international training accolades. Notably, he received a prestigious FAO-sponsored ‘Advanced Biorisk Training’ at the Australian Animal Health Laboratory in Geelong, Australia, in 2011.

Publications Noted & Contributions

Dr. S. Nandi has authored numerous publications, including books and book chapters, focusing on topics ranging from disease control strategies to advanced techniques in virus quantification. His contributions are pivotal in the field of Veterinary and Animal Sciences, addressing critical aspects of disease management and diagnostic methodologies.

Deciphering the genetic landscape of lumpy skin disease: Unraveling variable virulence through comprehensive genome sequence analysis in India

Authors: Mishra, R., Biswas, S.K., Nandi, S., Singh, R.K., Sharma, G.K.

Published in: Virology, 2024, 596, 110123

Abstract: This study explores the genetic variations of lumpy skin disease viruses in India, shedding light on their virulence factors and evolutionary dynamics.

High mortality in free-ranging wild boars associated with African swine fever virus in India

Authors: Sai Balaji, K.G., Karikalan, M., Saravanan, S., Singh, K.P., Sharma, G.K.

Published in: Archives of Virology, 2024, 169(7), 137

Abstract: Investigates the impact and mortality rates of African swine fever virus among wild boar populations in India, highlighting epidemiological concerns.

Development and evaluation of a chicken embryo fibroblast cell culture based live attenuated Indian strain duck plague vaccine

Authors: Dandapat, S., Bindu, S., Sharma, G.K., Saikumar, G., Dhama, K.

Published in: Veterinary Quarterly, 2024, 44(1), pp. 1–12

Abstract: Describes the development and testing of a live attenuated vaccine for duck plague using chicken embryo fibroblast cell cultures in India.

Spatio-temporal dynamics and distributional trend analysis of African swine fever outbreaks (2020–2021) in North-East India

Authors: Kimi, R., Beegum, M., Nandi, S., Singh, B.R., Vinodhkumar, O.R.

Published in: Tropical Animal Health and Production, 2024, 56(1), 39

Abstract: Analyzes the spatial and temporal patterns of African swine fever outbreaks in North-East India during 2020–2021, providing insights into disease spread.

Development and evaluation of recombinant gD protein based ELISA for sero-surveillance of BoHV-1 in India

Authors: Nautiyal, S., Nandi, S., Sharma, K., Singh, K.P., Sharma, G.K.

Published in: Biologicals, 2023, 84, 101720

Abstract: Details the development and assessment of a recombinant gD protein-based ELISA for detecting BoHV-1 antibodies in Indian cattle populations, aimed at enhancing surveillance efforts.

These articles reflect Dr. S. Nandi’s extensive research contributions in Veterinary Virology, focusing on various diseases and vaccine development strategies relevant to India’s livestock health and epidemiological landscape.

Research Timeline

Dr. S. Nandi’s research trajectory began with foundational studies during his Ph.D. program at I.V.R.I., where he explored the molecular aspects of viral assembly and antigenicity. Over the years, his research expanded to encompass a wide array of viral diseases, leading to significant advancements in understanding disease mechanisms and developing diagnostic tools. His career has been marked by continuous exploration and innovation in the field of Veterinary Virology.